SCM
Sandler Capital Management’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-17,033
| Closed | -$5.58M | – | 175 |
|
2024
Q4 | $5.58M | Buy |
+17,033
| New | +$5.58M | 0.58% | 48 |
|
2024
Q2 | – | Sell |
-14,694
| Closed | -$5.81M | – | 162 |
|
2024
Q1 | $5.81M | Sell |
14,694
-30,270
| -67% | -$12M | 0.42% | 59 |
|
2023
Q4 | $15.8M | Buy |
44,964
+27,210
| +153% | +$9.58M | 1.31% | 18 |
|
2023
Q3 | $6.66M | Buy |
17,754
+4,754
| +37% | +$1.78M | 0.69% | 37 |
|
2023
Q2 | $4.97M | Sell |
13,000
-1,964
| -13% | -$751K | 0.41% | 50 |
|
2023
Q1 | $5.18M | Buy |
+14,964
| New | +$5.18M | 0.47% | 46 |
|
2021
Q1 | – | Sell |
-11,477
| Closed | -$3.25M | – | 121 |
|
2020
Q4 | $3.25M | Sell |
11,477
-19,100
| -62% | -$5.41M | 0.38% | 51 |
|
2020
Q3 | $8.41M | Sell |
30,577
-55,693
| -65% | -$15.3M | 0.84% | 27 |
|
2020
Q2 | $19.6M | Buy |
+86,270
| New | +$19.6M | 1.87% | 8 |
|
2017
Q3 | – | Sell |
-70,024
| Closed | -$6.62M | – | 146 |
|
2017
Q2 | $6.62M | Sell |
70,024
-65,720
| -48% | -$6.21M | 0.72% | 31 |
|
2017
Q1 | $11.1M | Buy |
135,744
+25,844
| +24% | +$2.11M | 0.76% | 22 |
|
2016
Q4 | $9.32M | Buy |
109,900
+44,900
| +69% | +$3.81M | 0.84% | 30 |
|
2016
Q3 | $4.84M | Buy |
+65,000
| New | +$4.84M | 0.59% | 50 |
|
2015
Q3 | – | Sell |
-90,997
| Closed | -$5.29M | – | 174 |
|
2015
Q2 | $5.29M | Sell |
90,997
-45,083
| -33% | -$2.62M | 0.47% | 62 |
|
2015
Q1 | $8.19M | Sell |
136,080
-25,120
| -16% | -$1.51M | 0.51% | 59 |
|
2014
Q4 | $8.58M | Buy |
161,200
+81,200
| +102% | +$4.32M | 0.45% | 51 |
|
2014
Q3 | $3.58M | Buy |
+80,000
| New | +$3.58M | 0.17% | 95 |
|